News and Trends 14 Feb 2023 Scancell looking to partner after positive COVID vaccine data …cell response. RBD neutralizing antibody titres against the Beta variant doubled in 44% of subjects and NCAP antibody titres doubled in 42% of participants. Scancell said of particular interest was… February 14, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2017 New Antibodies to Target the Respiratory Syncytial Virus …an RSV therapy is already quite crowded, but Arsanis seems to be confident that their new antibody candidates have the potential to compete. Images via shutterstock.com / Kateryna Kon … February 28, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2025 XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry? …to BioInvent in exchange for upsizing our royalty.” The antibody drug was born from BioInvent’s n-CoDeR antibody library containing more than 30 billion human antibody genes stored within phage viruses… July 11, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 24 Apr 2024 Overcoming toxicities: are IL-2 smart cytokines the next big thing? …has two IL-2 smart cytokine candidates in the running. Its phase 1 candidate BNT151 is being developed to treat multiple solid tumors including head and neck cancer, liver cancer, and… April 24, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Jan 2025 Top 19 most-performing biotech stocks of 2024 …of MNPR-101-Lu, a novel radiopharmaceutical treating aggressive solid tumors. This is the candidate Monopar decided to prioritize after Validive’s mitigated results. This compound combines MNPR-101, a humanized monoclonal antibody that… January 27, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Dec 2024 Five biosimilar companies you should know about …Biogen Ongoing partnership with Merck for biosimilar candidates Samsung Bioepis is advancing a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology, ophthalmology, hematology,… December 5, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Dec 2024 Six biotech companies leading the way in India …rapid identification of selective and potent monoclonal antibodies with the potential to enhance antibody-dependent cellular cytotoxicity (ADCC) activity. Zumutor’s lead candidate, ZM008, is a first-in-class monoclonal antibody that disrupts the… December 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 24 Jul 2023 Sarcoma research: is a breakthrough in sight? …said Davies. Collaborating with researchers at University of California, Los Angeles (UCLA), CancerVAX’s Ewing sarcoma program is making progress, having created seven monoclonal antibody candidates, out of which six have… July 24, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Jun 2025 Six kidney disease companies you should know about in 2025 …Technology: APOL1 inhibitor Lead kidney disease candidate: MZE829 Recent news: Dosed the first patient in a phase 2 trial of MZE829 As a small molecule drug discovery company, Maze Therapeutics… June 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Jun 2024 Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024 …with a $35 million series A round. The Georgia company is focused on developing antiviral drugs particularly targeting respiratory viruses. The company’s lead candidate, vapendavir, is a broad-spectrum capsid inhibitor… June 25, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2017 Swiss-US Partners Reveal New Candidate for Autoimmune Disease Numab and Intarcia have a first candidate to combine a tri-specific antibody fragment with a mini-osmotic pump delivery system to fight autoimmune disease. Numab and Intarcia partnered in 2015 to… September 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Feb 2025 Seven biotech spinouts to watch out for in 2025 …KRAS is the most commonly mutated member of the RAS family, according to a study by Nature. The startup’s lead candidate BBO-8520 is a direct inhibitor that targets the ‘on’… February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email